Glenmark Pharma shares gain as USFDA gives nod to Tacrolimus

Glenmark Pharma: According to IQVIATM sales data for the 12‐month period ending June 30, the Protopic Ointment, 0.03 per cent achieved annual sales of approximately $15.4 million.

Related Keywords

United States , India , America , Glenn Saldanha , United States Food Drug Administration , Glenmark Pharmaceuticals Ltd , Glenmark Pharmaceuticals , Glenmark Pharmaceuticals Inc , United States Food , Drug Administration , Tacrolimus Ointment , Leo Pharma , Protopic Ointment , North America , Science Based Targets , Glenmark Pharma , Glenmark Pharma Shares , Glenmark Pharma Share Price , Lenmark Pharma Stock Price ,